Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Nov 14, 2013
Insider Transaction Report
Form 4
Aphale Jayant
SVP Technical Operations
Transactions
- Sale
Common Stock
2013-11-12$12.56/sh−15,933$200,134→ 8,500 total
Footnotes (1)
- [F1]Sale by broker in connection with a margin call.